• Research and Demonstration Projects: Brazil hosted three sites in the phase III iPrEx trial, and the open label extension of iPrEx. Brazil has an ongoing PrEP demonstration project in MSM and transgender women, PrEPBrasil. A second demonstration project is scheduled to start by mid-2015 and will enroll MSM, commercial sex workers and drug users.
  • Drug Registration: Gilead submitted an application for Truvada as PrEP to Brazil’s regulatory authority in 2014.
  • Policy/Regulatory: There is no national PrEP policy or guidance at present. However, the ongoing demonstration project may be used to inform such policy.
  • Advocacy: If you’re a Brazilian advocate working on PrEP, building a campaign or seeking to share insights and experience, please send info here and PrEPWatch will post it.

News Spotlight